Pentwater Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Pentwater Capital Management's BSX.PRA Position: Q1 2021 in Review
Pentwater Capital Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2021, closing a stake of 30,000 shares — an estimated $3.29M sold.
Pentwater Capital Management first reported a position in BSX.PRA in Q2 2020 and held it in 3 quarters. The position peaked at $3.36M in Q3 2020. 2 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2021.
- Pentwater Capital Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2021 after selling out during the quarter.
- Pentwater Capital Management sold 30,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2021, an estimated $3.29M.
- Pentwater Capital Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 3 quarters.
- Pentwater Capital Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.36M in Q3 2020.
- 2 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2021.
Based on Pentwater Capital Management's 13F filing for Q1 2021, filed 17 May 2021.